These Companies are Showing a Clear Path to Building Shareholder Value and a Hot New Feature Report
19 Abril 2022 - 7:00AM
InvestorsHub NewsWire
New York, NY -- April 19, 2022 -- InvestorsHub NewsWire -- via
Traders News Source, a leading independent equity research and
corporate access firm focused on small cap growth companies issues
new research reports and a hot new featured stock report.
The company advancing the PHILUX Global Funds, PHI Group,
Inc. (OTCPNK:
PHIL) announced earlier this month that an agreement
has been reached between Vietnam-based Ngoc Thien Phu Rice Export
Import JSC (NTP) and PHI Group, Inc. to participate in PHILUX
Global Food Fund (“PGFF”). According to the agreement, NTP will
contribute a mutually agreed amount of capital for the setup and
initial operating budget of the PGFF and hold 49% ownership of the
general partners’ portion of this fund. PGFF will focus on food and
food-related agricultural investment opportunities in Vietnam and
other countries as well. Healthy living property developer,
Alset EHome International Inc. (NASDAQ:
AEI) released its FYE 2021 financials and it seems the
company is doing well. The Group's revenue rose 21.9% to
approximately $19.8 million in FY2021 from $16.2 million in FY2020
due primarily to an increase in revenue from its biohealth business
and rental income under its real estate business. The Group's cash
has more than doubled from approximately $25.0 million as of
December 31, 2020, to $56.1 million as of December 31, 2021.
Find out more about NTP and the PHIL agreement and find out who has
been buying up shares of AEI and more in the full report READ MORE
Copy and paste to browser may be required - https://tradersnewssource.com/these-companies-are-showing-a-clear-path-to-building-shareholder-value-and-a-hot-new-feature-report/
The late-stage biotechnology company CytoDyn Inc. (OTCQB:
CYDY) is developing leronlimab, a CCR5 antagonist with
the potential for multiple therapeutic indications, has announced
the publication of a peer-reviewed research paper entitled
“Suppression of human and simian immunodeficiency virus replication
with the CCR5-specific antibody Leronlimab in two species” in the
open-access journal PLOS Pathogens. The study followed five HIV+
human participants who, after successfully transitioning to once
weekly subcutaneous leronlimab, halted their previous daily oral
antiretroviral therapy regimens. Argentum 47, Inc.
(OTCPNK:
ARGQ) has announced that management has fully executed
a legally binding letter of intent to acquire UK based company, The
Data Source Limited (TDS). Management has been in negotiations with
several parties since late 2021 in order to successfully complete a
merger or acquisition. TDS is a data driven B2B and B2C solutions
provider utilizing artificial intelligence with lead generation,
automation, and analytics. TDS provides its clients with world
class data with the aim of becoming a one-stop-shop for all things
data.
Get the details from the CYDY research paper and find out what the
acquisition by ARGQ could mean to shareholders READ MORE
Copy and paste to browser may be required - https://tradersnewssource.com/these-companies-are-showing-a-clear-path-to-building-shareholder-value-and-a-hot-new-feature-report/
Disclosure
Traders News Source LLC (TNS)
produces regular sponsored and non-sponsored reports, articles,
stock market blogs, and popular investment newsletters covering
small and micro-cap equity markets. TNS has two distinct and
independent departments. One department produces non-sponsored
analyst certified content generally in the form of press releases,
articles and reports covering equities listed on NYSE, NASDAQ, and
OTC exchanges. The other produces sponsored content (in most cases
not reviewed by a registered analyst), which typically consists of
compensated investment newsletters, articles and reports covering
listed stocks and micro-caps. Such sponsored content is outside the
scope of procedures detailed below.
PRESS RELEASE PROCEDURES
The non-sponsored content contained
herein has been prepared by a writer (the "Author") and is fact
checked and reviewed by a third-party research service company (the
"Reviewer") represented by a chartered financial analyst, for
further information on analyst credentials, please email
editor@tradersnewssource.com. TNS LLC provides necessary guidance
in preparing the document templates. The Reviewer has reviewed and
revised the content, as necessary, based on publicly available
information which is believed to be reliable. Content is
researched, written, and reviewed on a reasonable-effort basis. The
Reviewer has not performed any independent investigations or
forensic audits to validate the information herein. The Reviewer
has only independently reviewed the information provided by the
Author per the procedures outlined by TNS. TNS is not entitled to
veto or interfere in the application of such procedures by the
third-party research service company to the articles, documents, or
reports. Unless otherwise noted, any content outside of this
document has no association with the Author or the Reviewer in any
way.
NO WARRANTY
TNS, the Author, and the Reviewer are
not responsible for any error which may be occasioned at the time
of printing of this document or any error, mistake, or shortcoming.
No liability is accepted whatsoever for any direct, indirect, or
consequential loss arising from the use of this document. TNS, the
Author, and the Reviewer expressly disclaim any fiduciary
responsibility or liability for any consequences, financial or
otherwise arising from any reliance placed on the information in
this document. Additionally, TNS, the Author, and the Reviewer do
not (1) guarantee the accuracy, timeliness, completeness, or
correct sequencing of the information, or (2) warrant any results
from use of the information. The included information is subject to
change without notice.
NOT AN OFFERING
This document is not intended as an
offering, recommendation, or a solicitation of an offer to buy or
sell the securities mentioned or discussed and is to be used for
informational purposes only. Please read all associated disclosures
and disclaimers in full before investing. Neither TNS nor any party
affiliated with us is a registered investment adviser or
broker-dealer with any agency or in any jurisdiction whatsoever. To
download our report(s), read our disclosures, or for more
information, visit http://www.tradersnewssource.com.
For any questions, inquiries, or
comments reach out to us directly. If you're a company we are
covering and wish to no longer be featured on our coverage list,
contact us via email at: editor@tradersnewssource.com
CFA® and Chartered Financial Analyst®
are registered trademarks owned by CFA Institute.
CONTACT: editor@tradersnewssource.com
SOURCE: Traders News
Source
Argentum 47 (PK) (USOTC:ARGQ)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Argentum 47 (PK) (USOTC:ARGQ)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024
